CD44 also participates in the switch on different pathways (AKT, STAT3, β-catenin, among others) that activate, as a final event, different mesenchymal markers promoting invasion and metastasis in breast cancer cells [127–129]. This evidence concerns the gene STAT3 and breast carcinoma.